This phase 2 randomized clinical trial evaluates the effects of pazopanib in combination with paclitaxel vs paclitaxel and placebo on survival in patients with recurrent ovarian cancer.
http://ift.tt/2jU0Q28
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
-
http://ift.tt/2sxENoo
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου